Samrat Pharmachem [SAMRATPH] vs Navin Fluorine [NAVINFLUOR] Detailed Stock Comparison

Samrat Pharmachem Ltd.

BSE
Loading...

Navin Fluorine International Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Samrat Pharmachem Ltd. wins in 8 metrics, Navin Fluorine International Ltd. wins in 11 metrics, with 0 ties. Navin Fluorine International Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Samrat Pharmachem Ltd. Navin Fluorine International Ltd. Better
P/E Ratio (TTM) 39.68 57.84 Samrat Pharmachem Ltd.
Price-to-Book Ratio 0.98 8.89 Samrat Pharmachem Ltd.
Debt-to-Equity Ratio 15.49 32.68 Samrat Pharmachem Ltd.
PEG Ratio -0.34 0.28 Navin Fluorine International Ltd.
EV/EBITDA -93.75 35.28 Navin Fluorine International Ltd.
Profit Margin (TTM) -0.58% 17.74% Navin Fluorine International Ltd.
Operating Margin (TTM) -1.33% 30.42% Navin Fluorine International Ltd.
EBITDA Margin (TTM) N/A 30.42% N/A
Return on Equity 9.91% 10.99% Navin Fluorine International Ltd.
Return on Assets (TTM) 5.85% 5.97% Navin Fluorine International Ltd.
Free Cash Flow (TTM) $-105.99M $40.40M Navin Fluorine International Ltd.
Dividend Yield 0.29% 0.22% Samrat Pharmachem Ltd.
1-Year Return -41.18% 60.72% Navin Fluorine International Ltd.
Price-to-Sales Ratio (TTM) 0.24 10.45 Samrat Pharmachem Ltd.
Enterprise Value $597.84M $329.73B Navin Fluorine International Ltd.
EV/Revenue Ratio 0.21 10.72 Samrat Pharmachem Ltd.
Gross Profit Margin (TTM) 2.59% 58.79% Navin Fluorine International Ltd.
Revenue per Share (TTM) $936 $611 Samrat Pharmachem Ltd.
Earnings per Share (Diluted) $-5.42 $108.35 Navin Fluorine International Ltd.
Beta (Stock Volatility) -0.35 0.23 Samrat Pharmachem Ltd.

Samrat Pharmachem Ltd. vs Navin Fluorine International Ltd. Stock Performance Analysis

Loading Price Chart...

SAMRATPH
NAVINFLUOR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Samrat Pharmachem Ltd.0.55%-1.82%-3.65%-2.01%-20.44%-11.37%
Navin Fluorine International Ltd.-0.22%6.17%4.09%18.08%18.60%22.83%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Samrat Pharmachem Ltd.-41.18%-54.10%-17.42%588.68%951.05%2,351.16%
Navin Fluorine International Ltd.60.72%56.93%118.02%1,713.19%12,696.57%11,218.97%

Performance & Financial Health Analysis: Samrat Pharmachem Ltd. vs Navin Fluorine International Ltd.

MetricSAMRATPHNAVINFLUOR
Market Information
Market Cap i₹676.34M₹322.36B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,760159,766
90 Day Avg. Volume i2,391161,398
Last Close₹201.85₹7,287.00
52 Week Range₹190.00 - ₹389.00₹4,465.00 - ₹7,525.00
% from 52W High-48.11%-3.16%
All-Time High₹1,250.00 (Sep 19, 2022)₹7,525.00 (May 26, 2026)
% from All-Time High-83.85%-3.16%
Growth Metrics
Quarterly Revenue Growth0.00%0.47%
Quarterly Earnings Growth0.00%1.22%
Financial Health
Profit Margin (TTM) i-0.01%0.18%
Operating Margin (TTM) i-0.01%0.30%
Return on Equity (TTM) i0.10%0.11%
Debt to Equity (MRQ) i15.4932.68
Cash & Liquidity
Book Value per Share (MRQ)₹228.64₹705.31
Cash per Share (MRQ)₹62.79₹168.63
Operating Cash Flow (TTM) i₹1.26M₹4.60B
Levered Free Cash Flow (TTM) i₹71.12M₹2.89B
Dividends
Last 12-Month Dividend Yield i0.29%0.22%
Last 12-Month Dividend i₹1.00₹13.50

Valuation & Enterprise Metrics Analysis: Samrat Pharmachem Ltd. vs Navin Fluorine International Ltd.

MetricSAMRATPH (Apr 24, 2026)NAVINFLUOR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i39.6857.84
Forward P/E iN/A42.34
PEG Ratio i-0.340.28
Price to Sales (TTM) i0.2410.45
Price to Book (MRQ) i0.988.89
Market Capitalization
Market Capitalization i₹676.34M₹322.36B
Enterprise Value i₹597.84M₹329.73B
Enterprise Value Metrics
Enterprise to Revenue i0.2110.72
Enterprise to EBITDA i-93.7535.28
Risk & Other Metrics
Beta i-0.350.23
Book Value per Share (MRQ) i₹228.64₹705.31

Financial Statements Comparison: Samrat Pharmachem Ltd. vs Navin Fluorine International Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSAMRATPH (2025)NAVINFLUOR (2025)
Revenue/Sales i2.86B23.30B
Cost of Goods Sold i2.71B11.02B
COGS % of Revenue i94.7%47.3%
Gross Profit i152.75M12.27B
Gross Margin i5.3%52.7%
Research & Development i0N/A
Operating Income (EBIT) i97.54M4.14B
Operating Margin i3.4%17.8%
EBITDA i107.17M5.51B
EBITDA Margin i3.7%23.7%
Pre-Tax Income i98.86M3.80B
Pre-Tax Income % of Revenue i3.5%16.3%
Income Tax i27.74M914.90M
Income Tax % of Revenue i1.0%3.9%
Net Income (Profit) i71.12M2.89B
Profit Margin i2.5%12.4%

Balance Sheet & Liquidity Metrics

MetricSAMRATPH (2025)NAVINFLUOR (2025)
Cash & Equivalents i483,000196.80M
Total Current Assets i1.03B15.89B
Total Current Assets % of Revenue i36.2%68.2%
Total Current Liabilities i495.83M9.15B
Total Current Liabilities % of Revenue i17.3%39.3%
Long-Term Debt i010.67B
Long-Term Debt % of Revenue i0.0%45.8%
Total Shareholders Equity i718.00M26.26B
Retained Earnings i687.11M23.27B
Retained Earnings % of Revenue i24.0%99.9%
Property, Plant & Equipment i025.97B

Cash Flow Statement Comparison

MetricSAMRATPH (2025)NAVINFLUOR (2025)
Operating Cash Flow i1.26M4.60B
Operating Cash Flow % of Revenue i0.0%19.7%
Capital Expenditures i-5.07M-5.61B
Free Cash Flow i-105.99M40.40M
FCF Margin i-3.7%0.2%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSAMRATPHNAVINFLUOR
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i3.09M51.24M
Float Shares i1.19M36.18M
% Held by Insiders i59.26%29.38%
% Held by Institutions i0.00%39.84%
% Held by Public i40.74%30.78%

Dividend Analysis & Yield Comparison: Samrat Pharmachem Ltd. vs Navin Fluorine International Ltd.

MetricSAMRATPHNAVINFLUOR
Last 12-Month Dividend i₹1.00₹13.50
Last 12-Month Dividend Yield i0.29%0.22%
3-Year Avg Annual Dividend i₹1.67₹15.83
3-Year Avg Dividend Yield i0.17%0.16%
3-Year Total Dividends i₹5.00₹47.50
Ex-Dividend DateSep 19, 2024Nov 07, 2025